AGITG Call for Nominations

The Australasian Gastro-Intestinal Trials Group 2017 Annual General Meeting will be held on Friday 12th May, 12:45pm to 1:30pm, at Pullman Hotel Sydney Airport, 191 O’Riordan Street, Mascot, New South Wales. Nominations are hereby called to fill three vacancies on the Board of Directors. In accordance with clause 41 of … Read More

March 14, 2017

Interview with new Fellow

The AGITG has two new Research Fellows. This month we talked to Dr Namrata Nayar about her interest in GI cancer and what she hopes to achieve during her Fellowship over the next year. AGITG: Why did you decide to focus on GI cancer? Dr Nayar:   During my Oncology … Read More

March 13, 2017

Opportunities to attend the ASM

Special Offer Registration Rate Data Managers, Fellows and Registrars are eligible for a Special Offer Registration Rate of AUD$50 (normally $420). Conditions: Offer valid for the first 40 registrations for the Data Manager/Fellow/Registrar category only. You must attend the entire meeting to be eligible. Once the special offer rate is … Read More

March 13, 2017

AGITG Trial News

The AGITG currently has eight  studies open to recruitment and ten  studies in follow up. The  table below details  the trials that  are currently  accruing patients. Recruited Target ACTICCA-1- Gallbladder carcinoma 2 50 ALT-GIST- GI Stromal Tumour 44 60 ASCOLT — Colorectal cancer 197 300 CONTROL NETs — NeuroEndocrine Tumour … Read More

March 13, 2017

Two research studies to benefit patients

An invitation to participate in two research study surveys. Please consider participating in the surveys detailed below: Curtin University research study Please complete a brief (5mins) online questionnaire which is part of the following research study:  Knowledge, attitudes and practice of oncologists in promoting physical activity to cancer survivors Please … Read More

February 15, 2017

Work after Cancer

A new web resource to support return to work after cancer has been established by the team at the Flinders Centre for Innovation in Cancer, supported by Cancer Australia. The online resource  is aimed at supporting work during and after cancer diagnosis. The web resource is a result of a … Read More

February 15, 2017

Significant highlights for the AGITG

CommNETS abstract presented as oral presentation at ASCO GI. With great pleasure we inform you that  our abstract:  Development of follow up recommendations for completely resected gastroenteropancreatic neuroendocrine tumours (GEP-NETS): Practice Survey of Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) in conjunction with North American Neuroendocrine Tumour Society (NANETS)- was given an … Read More

February 15, 2017

Engage Forums featured at Conference

This year the Survivorship Conference was again held in Adelaide in February. The conference brings together a diverse group of clinicians, researchers, policy makers and consumers from around Australia and beyond to make a lasting impact on the lives of those affected by cancer. The theme this year was “Cancer … Read More

February 14, 2017

First patient randomised for InterAACT

The first Australian patient has been randomised to the InterAACT study. This patient was from Austin Hospital (PI: A/Prof Niall Tebbutt) and was randomised 4th January 2017. More patients are needed so referrals are welcome. InterAACT is an international, multicentre trial aiming to establish which chemotherapy regimen is more effective … Read More

February 14, 2017

ALaCaRT recognised by ASCO

The ALaCaRT rectal surgery trial was recently selected by the  American Society of Clinical Oncology  for inclusion in  Clinical Cancer Advances 2017, the society’s annual review of progress against cancer and emerging trends in the field. The study has been featured as one of the year’s major achievements internationally in … Read More

February 2, 2017